 Hypothesis: investigators propose that Docosahexaenoic acid DHA supplementation, early in pregnancy, reduces the incidence of deep placentation disorders preterm birth, preterm labor, preterm premature rupture of membranes, preeclampsia and fetal growth restriction, by improving deep placentation physiology: invasion and transformation of spiral arteries by trophoblast. 